Fundz
Funding, M&A and exec moves matched to your market, from $49/mo billed annually, or $79/mo quarterly. See plans and pricing.See plans →

VION Biosciences acquires Prolytix for growth

PRIVATESep 08, 2026about 3 hours ago

Acquiring Company

VION Biosciences

Acquired Company

Prolytix

CharlottesvilleBurlingtonBiotechnologyLife ScienceBiotechnology

Description

VION Biosciences has successfully completed the acquisition of Prolytix. This acquisition enhances VION's capabilities in regulated bioanalytical and CMC services. It supports the company’s strategic goal of developing a comprehensive life science platform. This integration will streamline workflows across biopharma services and diagnostics.

Company Information

Company

VION Biosciences

Location

Charlottesville, Virginia, United States

About

VION Biosciences is a life science platform company focused on specialty reagents in the life science research, diagnostic, and drug discovery space. It is the second investment under VION Biosciences LLC, Iron Path Capital’s roll-up platform in the life science sector. VION Biosciences aims to transcend into the drug manufacturing space and enhance customer access to specialized products and technologies through targeted expansion of the VION product portfolio.

Don't miss VION Biosciences's next move

Get an email the moment VION Biosciences makes an acquisition, hires an exec, or expands, usually minutes after it happens.

One email per event. Unsubscribe anytime.

Related People

Mark
Likely contact at this company
••••••••@••••••••

See Mark's verified email →

Predictive Intelligence
Strategic

ML-powered predictions for VION Biosciences's next move

Learn about Strategic plan

M&A Insights

Based on deal data
Integration timeline
70% of M&A integrations take 12-24 months to complete
Tech stack consolidation
83% of merged companies consolidate technology vendors within first year
Post-acquisition investment
Companies increase IT spending by 23% on average after acquisitions
Success factor
M&A deals with strong technology integration plans are 2.5x more likely to succeed

Frequently asked

Who acquired Prolytix?

Prolytix was acquired by VION Biosciences, based in Charlottesville. The deal was reported on September 8, 2026. VION Biosciences is a life science platform company focused on specialty reagents in the life science research, diagnostic, and drug discovery space. VION Biosciences is privately held and operates in Biotechnology.

When did VION Biosciences acquire Prolytix?

VION Biosciences's acquisition of Prolytix was reported on September 8, 2026. VION Biosciences has successfully completed the acquisition of Prolytix. This acquisition enhances VION's capabilities in regulated bioanalytical and CMC services. It supports the company’s strategic goal of developing a comprehensive life science platform. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.

What does Prolytix do?

Prolytix is a leading provider of analytical and bioanalytical services supporting the research, development, and commercialization of large-molecule biotherapeutics and high-quality reagents for coagulation research. It is privately held, operating in Biotechnology, and is based in Burlington.

This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.

145 of these a day, filtered to the companies you pick. $29 a month, billed annually, and if it does not pay for itself in a year we refund it.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 200,000+ companies. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.